Up to 56% of patients tapering antidepressants get withdrawal symptoms, and most PMHNP programs still teach the half-pill method that drives those symptoms. This episode breaks down the hyperbolic tapering approach that's becoming the 2026 standard. You'll hear: - Why receptor occupancy stays high at low doses, so 20→10 mg feels mild but 5→0 mg crashes patients - How to build a hyperbolic schedule using liquid suspensions or compounded mini-doses (and what to do when the pharmacy pushes back) - The patient-facing language that keeps people on the plan instead of cold-turkeying when discontinuation symptoms hit at week three Full protocol, dosing tables, and the timeline script: https://psychnpfellowship.com/hyperbolic-antidepressant-tapering-pmhnp-protocol-2026/ The Deep Dive with Lindsay Hill, DNP, PMHNP — two AI hosts unpacking the blog for new ...